REGULATED PRESS RELEASE published on 09/25/2024 at 17:45, 1 year 2 months ago COGELEC : Results for H1 2024. Strong revenue growth: +12.4% (€36.7m). Sharp increase in EBITDA: +33.7% (€6.1m). Annual targets confirmed. COGELEC releases strong H1 2024 results: revenue +12.4% (€36.7m) and EBITDA +33.7% (€6.1m). Annual targets confirmed. Details on financial performance and growth strategies EBITDA Revenue Growth COGELEC Annual Targets H1 2024 Results
BRIEF published on 09/11/2024 at 17:45, 1 year 2 months ago COGELEC: Statement on the Total Number of Shares and Voting Rights Voting Rights Shares Financial Statement COGELEC Euronext Growth
REGULATED PRESS RELEASE published on 09/11/2024 at 17:40, 1 year 2 months ago COGELEC : Statement on the total number of shares and voting rights. COGELEC releases statement on total shares and voting rights as of August 31, 2024, in compliance with regulations. Leading in access control systems, listed on Euronext Growth Paris Euronext Growth Paris Voting Rights Shares COGELEC Access Control Systems
BRIEF published on 08/29/2024 at 17:45, 1 year 3 months ago COGELEC: Statement on the Total Number of Shares and Voting Rights Voting Rights Shares Euronext COGELEC Financial Markets
REGULATED PRESS RELEASE published on 08/29/2024 at 17:40, 1 year 3 months ago COGELEC : Statement on the total number of shares and voting rights. COGELEC provides statement on total shares and voting rights as of July 31, 2024, in compliance with French Commercial Code and Financial Markets Authority regulations. Trading on Euronext Growth Paris Voting Rights French Commercial Code Shares Euronext COGELEC
BRIEF published on 07/18/2024 at 17:50, 1 year 4 months ago COGELEC Reports 12.4% Revenue Growth in H1 2024 COGELEC Double-digit Growth International Sales Subscription Growth H1 2024 Revenue
REGULATED PRESS RELEASE published on 07/18/2024 at 17:45, 1 year 4 months ago COGELEC : H1 2024 revenue: €36.7m (+12.4%). Solid sales momentum over the half-year. Full-year growth targets confirmed. COGELEC reports solid H1 2024 revenue growth of 12.4%, confirming full-year targets for double-digit revenue growth and improved profitability. Strong sales momentum in France and internationally Revenue Growth COGELEC International France Full-year Targets
BRIEF published on 07/09/2024 at 17:45, 1 year 4 months ago COGELEC Announces Total Shares and Voting Rights as of June 30, 2024 Voting Rights Shares Financial Markets Authority COGELEC Euronext Growth
BRIEF published on 07/09/2024 at 17:45, 1 year 4 months ago COGELEC: Half-yearly review of the liquidity contract Liquidity Contract Financial Transactions Half-yearly Report COGELEC
REGULATED PRESS RELEASE published on 07/09/2024 at 17:40, 1 year 4 months ago COGELEC : Statement on the total number of shares and voting rights. COGELEC issues statement on total number of shares and voting rights as of June 30, 2024, in compliance with French Commercial Code and Financial Markets Authority regulations Voting Rights French Commercial Code Shares COGELEC Financial Markets
Published on 12/05/2025 at 02:35, 4 hours 59 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 34 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 29 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 34 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 34 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 4 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 43 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 9 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 19 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 34 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 49 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 50 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025